Advertisement
Advertisement
ONC
BeOne Medicines Ltd. - ADR
310.25
USDSponsored
+0.63
+0.20%
May 22, 16:00 UTC -4
Closed
Pre-Market
308.01
-2.24
-0.72%
ONC Earnings Reports
Positive Surprise Ratio
ONC beat 5 of 17 last estimates.
29%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
BeOne Medicines Ltd. - ADR earnings per share and revenue
On May 06, 2026, ONC reported earnings of 13.35 USD per share (EPS) for Q1 26, beating the estimate of 1.32 USD, resulting in a 2597.62% surprise. Revenue reached 10.31 billion, compared to an expected 10.93 billion, with a -1.83% difference. The market reacted with a +5.32% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
Galectin Therapeutics Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.08
Surprise
-30.72%
Marker Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.44%
PLUS THERAPEUTICS, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.89
Actual
-$1.05
Surprise
-16.98%
Wellgistics Health, Inc. Common Stock
Report Date
May 19, 2026 For Q1 26
Estimate
-Actual
-$0.07
Surprise
-
Vivos Therapeutics, Inc. Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.46
Actual
-$0.52
Surprise
-12.46%
Traws Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.75
Actual
-$0.53
Surprise
+29.78%
Cosmos Holdings Inc. Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.01
Actual
-$0.06
Surprise
-488.24%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
AIM ImmunoTech Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.37
Actual
-$0.56
Surprise
-52.53%
FAQ
What were BeOne Medicines Ltd. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, BeOne Medicines Ltd. - ADR reported EPS of $13.35, beating estimates by 2597.62%, and revenue of $10.31B, -1.83% below expectations.
How did the market react to BeOne Medicines Ltd. - ADR's Q1 2026 earnings?
The stock price moved up 5.32%, changed from $297.49 before the earnings release to $313.32 the day after.
When is BeOne Medicines Ltd. - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for BeOne Medicines Ltd. - ADR's next earnings report?
Based on --
analysts, BeOne Medicines Ltd. - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement